Medical Park Hospitals Group MD, Assoc. Prof. Neurosurgeon, Sait Öztürk has successfully accomplished Brain Pacemaker surgery while awake and watching cartoons to DYSTONIA PATIENT ZEYNEP
ISTANBUL, March 15, 2023 /PRNewswire/ -- Zeynep Liva Elmacı, a dystonia patient who has been having uncontrollable involuntary contractions in her legs and arms for the last 5 years, underwent brain pacemaker surgery while awake by watching cartoons. The patient's surgery was performed Medical Park, Turkey's health power with 27 Hospitals and...
YS BIOPHARMA AND SUMMIT HEALTHCARE ANNOUNCE SHAREHOLDER APPROVAL OF BUSINESS COMBINATION
Business Combination to deliver approximately $36 million of gross proceeds YS Biopharma expects to close the Business Combination on March 16, 2023 YS Biopharma Ordinary Shares and YS Biopharma Warrants expected to begin trading on the Nasdaq on March 17, 2023 under the symbols "YS" and "YSBPW," respectively NEW...
Medical Tourism Moonshot: Breaking the Barriers to Quality Healthcare
PALM BEACH GARDENS, Fla., March 15, 2023 /PRNewswire/ -- The Medical Tourism Association in collaboration with Global Healthcare Resources and the International Healthcare Research Center have launched the first Medical Tourism Moonshot to break down the major barriers preventing access and growth in medical tourism. With a target to add 5 million...
Mabwell Launched First in human Clinical Trial of Its Iron Homeostasis Regulating Macromolecular Drug 9MW3011
SHANGHAI, March 14, 2023 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, launched first in human clinical trial of its iron homeostasis regulating macromolecular drug 9MW3011. The study (CTR20230046) is a phase 1, single center, randomized, double-blind，placebo-controlled, ascending dose study to evaluate the safety, tolerability, pharmacokinetic, pharmacodynamics and immunogenicity of 9MW3011 in...
Picarro’s New 1-ppb Class Chemical Metrology Solution for Lithography Process Tool Monitoring Enables Semiconductor Fabs to Improve Process Control
SLiM 100 delivers real-time detection and quantification of VOCs to the 1 ppb level SANTA CLARA, Calif., March 14, 2023 /PRNewswire/ -- Picarro Inc., a leading provider of chemical metrology systems for advanced semiconductor fabs, today announced the SLiM 100 Lithography Process Tool Monitoring System. The new 1-ppb class chemical metrology solution detects volatile organic compounds (VOCs) in...
USAID-FUNDED PROJECT RECOGNIZES EIGHT ORGANIZATIONS FOR LEADERSHIP IN ADOPTING ANTIMICROBIAL USE STEWARDSHIP PRINCIPLES
Developed by the International Poultry Council, the principles aim to optimize animal health to reduce reliance on antimicrobials TUCKER, Ga., March 14, 2023 /PRNewswire/ -- The International Poultry Council (IPC) is pleased to announce eight private-sector organizations have recognized the importance of responsible antimicrobial use and are endorsing the council's antimicrobial use...
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results
New Business Strategy Focused on Precision Oncology LONDON and HONG KONG, March 14, 2023 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics and precision oncology company, today announced financial results for the fourth quarter and full year ended December 31, 2022. Financial Highlights Revenue of US$275.8 million in the full year 2022...
Servier’s Pivotal Phase 3 INDIGO Trial Investigating vorasidenib in IDH-Mutant Low-Grade Glioma Meets Primary Endpoint of Progression-Free Survival (PFS) and Key Secondary Endpoint of Time to Next Intervention (TTNI)
Clinically meaningful achievement of primary and secondary endpoints is first major advance in treatment of low-grade glioma in more than 20 years Endpoints met in a prespecified interim analysis vorasidenib granted fast track designation by U.S. Food & Drug Administration (FDA) PARIS and BOSTON, March 14, 2023 /PRNewswire/ -- Servier, a global pharmaceutical group, announced today that...
Ajinomoto Bio-Pharma Services Awarded Three ‘CDMO Leadership Awards’
SAN DIEGO and TOKYO and WETTEREN, Belgium, March 14, 2023 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, received three CDMO Leadership Awards in the categories Capabilities, Compatibility, and Expertise in both the Overall and Big Pharma respondent groups. Established in 2011, the...
Simcere Zaiming Announces Clinical Collaboration to Evaluate SIM0235, a TNFR2 Monoclonal Antibody, in Combination with KEYTRUDA® (pembrolizumab) in a Phase 1 Trial in Advanced Solid Tumors and Cutaneous T-cell...
NANJING, China, March 14, 2023 /PRNewswire/ -- Simcere Pharmaceutical Group Limited (2096.HK) (Simcere), an innovative global biopharmaceutical company, announced today that Simcere Zaiming, an innovative oncology pharmaceutical company of Simcere has entered into a clinical collaboration agreement with MSD (Merck & Co., Inc., Rahway, NJ, USA) to evaluate the combination of SIM0235, a potential first-in-class humanized anti-tumor necrosis factor...
